Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 13Breast Neoplasms 6Head and Neck Neoplasms 3Disease 3Prostatic Neoplasms 2Melanoma 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Vasculitis 1Urinary Bladder Neoplasms 1Tobacco Use Cessation 1Testicular Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sinusitis 1Recurrence 1Rectal Neoplasms 1Osteomyelitis 1Neoplasms 1Neoplasm Metastasis 1Liver Cirrhosis 1Hematuria 1Heart Diseases 1Hearing Loss 1Gastrointestinal Neoplasms 1Fistula 1Fever of Unknown Origin 1Esophageal Neoplasms 1

Interventions

Cystoscopy 2Urinalysis 1Tomography, X-Ray Computed 1Microscopy, Confocal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hematuria × Tomography, X-Ray Computed × Clear all
NCT05362539 2022-05-05

Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria

Mansoura University

Phase NA Completed
246 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hematuria

Data powered by HemOnc (CC BY 4.0) Colophon âš¡